Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01785030 · ClinicalTrials.gov registry record · Phase 1
Nitrous Oxide Vasodilation Healthy Adult Volunteers
A Phase 1 study, sponsored by Columbia University.
- Terminated
- Registry status
- Phase 1
- Development phase
- 7
- Enrollment target
NCT01785030 is a Phase 1 study that was terminated before completion, run by Columbia University. The registered enrollment target is 7 participants.
The verdict
NCT01785030, a Phase 1 study, was terminated before completion, sponsored by Columbia University.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 7 participants
- Enrollment target
Study Summary
Nitrous oxide (N2O) is a gas that is normally used to take away pain and anxiety during painful medical procedures. However, one of its effects is to also make veins appear larger and more visible. This is useful when there is a patient who needs to have an intravenous (IV) needle put in their skin to give them medicine or fluids, but may have veins that are very hard to see or feel. The mechanism of this observed effect is not entirely clear. The purpose of this study is to use an ultrasound to directly measure whether there is an actual change size of veins or change in blood flow in healthy adult volunteers when you give them 50% nitrous oxide, and see whether or not this change in size, or change in flow, is what causes the changes in visibility or palpability of the vein.
Interventions
- DRUG 50% Nitrous oxide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2013-02 |
| Est. Completion | 2017-02 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01785030
The ClinicalTrials.gov registry entry for NCT01785030 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which 50% Nitrous oxide is the first listed.
NCT01785030 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01785030 about?
NCT01785030 is a clinical study titled "Nitrous Oxide Vasodilation Healthy Adult Volunteers". Nitrous oxide (N2O) is a gas that is normally used to take away pain and anxiety during painful medical procedures. However, one of its effects is to also make veins appear larger and more visible. This is useful when there is a patient who needs to have an intravenous (IV) needle put in their skin ...
What is the current status of trial NCT01785030?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 7 participants. The study started on 2013-02. Estimated completion is 2017-02.
What interventions are being tested in trial NCT01785030?
The interventions under investigation include: 50% Nitrous oxide (DRUG).
Who is sponsoring clinical trial NCT01785030?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.